DK1962889T3 - Immunogent polypeptid nestående af tumorantigenafledte optimerede kryptiske peptider samt anvendelser deraf - Google Patents

Immunogent polypeptid nestående af tumorantigenafledte optimerede kryptiske peptider samt anvendelser deraf

Info

Publication number
DK1962889T3
DK1962889T3 DK05850393T DK05850393T DK1962889T3 DK 1962889 T3 DK1962889 T3 DK 1962889T3 DK 05850393 T DK05850393 T DK 05850393T DK 05850393 T DK05850393 T DK 05850393T DK 1962889 T3 DK1962889 T3 DK 1962889T3
Authority
DK
Denmark
Prior art keywords
well
applications
tumor antigen
immunogenic polypeptide
polypeptide
Prior art date
Application number
DK05850393T
Other languages
English (en)
Inventor
Konstantinos Kosmatopoulos
Sebastien Cornet
Original Assignee
Vaxon Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vaxon Biotech filed Critical Vaxon Biotech
Application granted granted Critical
Publication of DK1962889T3 publication Critical patent/DK1962889T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515Animal cells
    • A61K2039/5154Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515Animal cells
    • A61K2039/5158Antigen-pulsed cells, e.g. T-cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
DK05850393T 2005-12-23 2005-12-23 Immunogent polypeptid nestående af tumorantigenafledte optimerede kryptiske peptider samt anvendelser deraf DK1962889T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2005/014212 WO2007073768A1 (en) 2005-12-23 2005-12-23 Immunogenic polypeptide composed of tumor antigen-derived optimized cryptic peptides, and uses thereof

Publications (1)

Publication Number Publication Date
DK1962889T3 true DK1962889T3 (da) 2009-11-02

Family

ID=36000393

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05850393T DK1962889T3 (da) 2005-12-23 2005-12-23 Immunogent polypeptid nestående af tumorantigenafledte optimerede kryptiske peptider samt anvendelser deraf

Country Status (12)

Country Link
US (1) US7973128B2 (da)
EP (1) EP1962889B1 (da)
JP (1) JP4929290B2 (da)
CN (1) CN101370513B (da)
AT (1) ATE435660T1 (da)
CA (1) CA2634480C (da)
DE (1) DE602005015368D1 (da)
DK (1) DK1962889T3 (da)
ES (1) ES2330658T3 (da)
PL (1) PL1962889T3 (da)
PT (1) PT1962889E (da)
WO (1) WO2007073768A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012523379A (ja) * 2009-04-09 2012-10-04 ザ ユニバーシティー オブ メルボルン 免疫原性組成物およびその使用
CN102153658A (zh) * 2011-01-19 2011-08-17 上海科医联创生物科技有限公司 肿瘤抗原、dc肿瘤疫苗及其制备方法
EP2886127A1 (en) 2013-12-18 2015-06-24 Vaxon Biotech Method for emulsifying a triepitope peptide with montanide and kits for performing the same
EP2977059A1 (en) 2014-07-22 2016-01-27 Vaxon Biotech Immunogenic polypeptide composed of HLA-B7 restricted tumor antigen-derived optimized cryptic peptides, and uses thereof
CN104926944B (zh) * 2015-05-22 2018-04-13 北京康爱瑞浩生物科技股份有限公司空港分公司 多靶点复合抗原负载cd8+细胞毒性t淋巴细胞的制备方法及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2393738A1 (en) * 1999-12-10 2001-06-14 Epimmune Inc. Inducing cellular immune responses to her2/neu using peptide and nucleic acid compositions
ES2276788T3 (es) * 2000-05-10 2007-07-01 Sanofi Pasteur Limited Polipeptidos inmunogenos codificados por minigenes mage y sus utilizaciones.
FR2812087B1 (fr) * 2000-07-21 2007-05-11 Inst Nat Sante Rech Med Procede de criblage de peptides utilisables en immunotherapie

Also Published As

Publication number Publication date
CN101370513A (zh) 2009-02-18
EP1962889A1 (en) 2008-09-03
WO2007073768A1 (en) 2007-07-05
US20090130133A1 (en) 2009-05-21
ATE435660T1 (de) 2009-07-15
JP4929290B2 (ja) 2012-05-09
DE602005015368D1 (de) 2009-08-20
PL1962889T3 (pl) 2010-03-31
CN101370513B (zh) 2013-04-03
US7973128B2 (en) 2011-07-05
CA2634480C (en) 2013-10-15
CA2634480A1 (en) 2007-07-05
PT1962889E (pt) 2009-10-14
EP1962889B1 (en) 2009-07-08
JP2009520472A (ja) 2009-05-28
ES2330658T3 (es) 2009-12-14

Similar Documents

Publication Publication Date Title
HK1134507A1 (en) Peptide vaccines for cancers expressing tumor-associated antigens
NZ593598A (en) Optimized antiviral vaccines with improved cellular immunogenicity
EP3552622A3 (en) Priming of an immune response
CA2817709C (en) Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same
UA110599C2 (uk) Пептид для імунотерапії пухлин, включаючи нейрональні пухлини та пухлини мозку
IL182357A0 (en) Malaria prime/boost vaccines
DK2014678T3 (da) KDR-peptider og vacciner indeholdende disse
NZ702145A (en) Bluetongue virus recombinant vaccines and uses thereof
MXPA02006888A (es) Flavivirus recombinantes y metodos para utilizar los mismos.
HK1091217A1 (en) Tuberculosis vaccine with improved efficacy
DK1962889T3 (da) Immunogent polypeptid nestående af tumorantigenafledte optimerede kryptiske peptider samt anvendelser deraf
WO2016130628A8 (en) Griffithsin mutants
MX2009007261A (es) Vacuna de peptido foxp3.
DK2289533T3 (da) Epitoppeptider afledt af karendothelvækstfaktorreceptor-1 samt vacciner indeholdende disse peptider
NZ598605A (en) Vaccine against african horse sickness virus
MX2010005816A (es) Epítopos de péptido de stat3.
TW201008576A (en) New fusion proteins and their use for the preparation of vaccines against hepatitis C
UA102274C2 (ru) Эпитопный пептид rab6kifl/kif20a и вакцины, которые его содержат
MX2010010025A (es) Proteina de fusion con direccionamiento de antigenos vacunales a celulas presentadoras de antigeno y sus aplicaciones.
PH12018502430A1 (en) Vaccines
WO2009083968A8 (en) Novel protein
EP2370454A4 (en) PEPTIDES WITH EPITAOPE WDRPUH AND VACCINES INCLUDING THEM
WO2009149094A3 (en) Cytotoxic t cell defined egfr peptide and an optimized derivative peptide
PE20001367A1 (es) Sintesis recombinante de beta-lipotropina y otros peptidos
TH88495B (th) วัคซีนชนิดใหม่สำหรับปรสิตทางทะเล